Nicotine-stimulated release of [3H]norepinephrine is reduced in the hippocampus of an animal model of attention-deficit/hyperactivity disorder, the spontaneously hypertensive rat

Brain Research

Volumn 1572, Issue , 2014, Pages 1-10

  Sterley, Toni Lee ^a   Howells, Fleur M ^a   Russell, Vivienne A ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Attention deficit hyperactivity disorder; Hippocampus; Nicotine; Norepinephrine; Spontaneously hypertensive rat

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BICUCULLINE; GLUTAMIC ACID; NICOTINE; NORADRENALIN; POTASSIUM; AMPA RECEPTOR; NICOTINIC AGENT; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DESENSITIZATION; HIPPOCAMPUS; INCUBATION TIME; LOCUS CERULEUS; MALE; NEGATIVE FEEDBACK; NEUROPATHOLOGY; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SPRAGUE DAWLEY RAT; VALIDATION STUDY; VARICOSIS; WISTAR KYOTO RAT; ANIMAL; DISEASE MODEL; DRUG EFFECTS; METABOLISM; SPECIES DIFFERENCE;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MALE; NICOTINE; NICOTINIC AGONISTS; NOREPINEPHRINE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, GABA-A; SPECIES SPECIFICITY; TRITIUM;

EID: 84903604648     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.05.005     Document Type: Article

References (82)

1. F.A. Abdulla, E. Bradbury, M.R. Calaminici, P.M. Lippiello, S. Wonnacott, J.A. Gray, and J.D. Sinden Relationship between up-regulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulation Psychopharmacology 124 1996 323 331
2. M. Alkondon, M.F. Braga, E.F. Pereira, A. Maelicke, and E.X. Albuquerque Alpha7 nicotinic acetylcholine receptors and modulation of gabaergic synaptic transmission in the hippocampus Eur. J. Pharmacol. 393 2000 59 67
3. M. Alkondon, E.F. Pereira, C.T. Barbosa, and E.X. Albuquerque Neuronal nicotinic acetylcholine receptor activation modulates gamma-aminobutyric acid release from CA1 neurons of rat hippocampal slices J. Pharmacol. Exp. Ther. 283 1997 1396 1411
4. A.F. Arnsten The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder Expert. Rev. Neurother. 10 2010 1595 1605
5. J. Barik, and S. Wonnacott Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal Mol. Pharmacol. 69 2006 618 628
6. C.W. Berridge, and B.D. Waterhouse The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes Brain Res. Rev. 42 2003 33 84
7. J.F. Blake, M.W. Brown, and G.L. Collingridge CNQX blocks acidic amino acid induced depolarizations and synaptic components mediated by non-NMDA receptors in rat hippocampal slices Neurosci. Lett. 89 1988 182 186
8. J.F. Blake, R.G. Yates, M.W. Brown, and G.L. Collingridge 6-Cyano-7-nitroquinoxaline-2,3-dione as an excitatory amino acid antagonist in area CA1 of rat hippocampus Br. J. Pharmacol. 97 1989 71 76
9. M.P. Blaustein, E.M. Johnson Jr., and P. Needleman Calcium-dependent norepinephrine release from presynaptic nerve endings in vitro Proc. Natl. Acad. Sci. USA 69 1972 2237 2240
10. G. Bonanno, and M. Raiteri A carrier for GABA uptake exists on noradrenaline nerve endings in selective rat brain areas but not on serotonin terminals J. Neural Transm. 69 1987 59 70
11. J.R. Booth, D.D. Burman, J.R. Meyer, Z. Lei, B.L. Trommer, N.D. Davenport, W. Li, T.B. Parrish, D.R. Gitelman, and M. Marsel Mesulam Larger deficits in brain networks for response inhibition than for visual selective attention in attention deficit hyperactivity disorder (ADHD) J. Child Psychol. Psychiatry 46 2005 94 111
12. P. Brambilla, J. Perez, F. Barale, G. Schettini, and J.C. Soares GABAergic dysfunction in mood disorders Mol. Psychiatry 8 721-737 2003 715
13. N. Breslau, M. Kilbey, and P. Andreski Nicotine dependence and major depression: new evidence from a prospective investigation Arch. Gen. Psychiatry 50 1993 31 35
14. 3H]-dopamine release Br. J. Pharmacol. 117 1996 595 606
15. H. Czyzewska-Szafran, M. Wutkiewicz, M. Remiszewska, Z. Jastrzebski, A. Czarnecki, and A. Danysz Down-regulation of the GABA-ergic system in selected brain areas of spontaneously hypertensive rats (SHR) Pol. J. Pharmacol. Pharm. 41 1989 619 627
16. J.A. Davis, and T.J. Gould Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning Neuropsychopharmacology 32 2007 2011 2019
17. G. Engberg, L. Oreland, P. Thoren, and T. Svensson Locus coeruleus neurons show reduced alpha 2-receptor responsiveness and decreased basal activity in spontaneously hypertensive rats J. Neural Transm. 69 1987 71 83
18. M. Ernst, A.S. Kimes, E.D. London, J.A. Matochik, D. Eldreth, S. Tata, C. Contoreggi, M. Leff, and K. Bolla Neural substrates of decision making in adults with attention deficit hyperactivity disorder Am. J. Psychiatry 160 2003 1061 1070
19. R. Fabian-Fine, P. Skehel, M.L. Errington, H.A. Davies, E. Sher, M.G. Stewart, and A. Fine Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus J. Neurosci. 21 2001 7993 8003
20. S.V. Faraone, and J. Biederman What is the prevalence of adult ADHD? Results of a population screen of 966 adults J. Atten. Disord. 9 2005 384 391
21. S.V. Faraone, J. Biederman, T. Spencer, T. Wilens, L.J. Seidman, E. Mick, and A.E. Doyle Attention-deficit/hyperactivity disorder in adults: an overview Biol. Psychiatry 48 2000 9 20
22. S.V. Faraone, and A.E. Doyle Genetic influences on attention deficit hyperactivity disorder Curr. Psychiatry Rep. 2 2000 143 146
23. S.V. Faraone, J. Sergeant, C. Gillberg, and J. Biederman The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2 2003 104 113
24. A. Fassio, F. Rossi, G. Bonanno, and M. Raiteri GABA induces norepinephrine exocytosis from hippocampal noradrenergic axon terminals by a dual mechanism involving different voltage-sensitive calcium channels J. Neurosci. Res. 57 1999 324 331
25. Y. Fu, S.G. Matta, T.J. James, and B.M. Sharp Nicotine-induced norepinephrine release in the rat amygdala and hippocampus is mediated through brainstem nicotinic cholinergic receptors J. Pharmacol. Exp. Ther. 284 1998 1188 1196
26. M. Gattu, J.R. Pauly, K.L. Boss, J.B. Summers, and J.J. Buccafusco Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. I Brain Res. 771 1997 89 103
27. R. Giniatullin, A. Nistri, and J.L. Yakel Desensitization of nicotinic ACh receptors: shaping cholinergic signaling Trends Neurosci. 28 2005 371 378
28. T.J. Gould, M. Rukstalis, and M.C. Lewis Atomoxetine and nicotine enhance prepulse inhibition of acoustic startle in C57BL/6 mice Neurosci. Lett. 377 2005 85 90
29. E.J. Hohnadel, C.M. Hernandez, D.A. Gearhart, and A.V. Terry Jr. Effect of repeated nicotine exposure on high-affinity nicotinic acetylcholine receptor density in spontaneously hypertensive rats Neurosci. Lett. 382 2005 158 163
30. F.M. Howells, L. Bindewald, and V.A. Russell Cross-fostering does not alter the neurochemistry or behavior of spontaneously hypertensive rats Behav. Brain Funct. 5 2009 24
31. F.M. Howells, and V.A. Russell Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/ hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety- like behaviours (Wistar-Kyoto rat) Brain Res. 1200 2008 107 115
32. G.L. Humfleet, J.J. Prochaska, M. Mengis, J. Cullen, R. Munoz, V. Reus, and S.M. Hall Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure Nicot. Tob. Res. 7 2005 453 460
33. B receptor functions in various brain regions of spontaneously hypertensive rats Neurochem. Res. 23 1998 89 95
34. S.T. Kaehler, P. Salchner, N. Singewald, and A. Philippu Differential amino acid transmission in the locus coeruleus of Wistar-Kyoto and spontaneously hypertensive rats Naunyn Schmiede. Arch. Pharmacol. 370 2004 381 387
35. A.V. Kalueff, and D.J. Nutt Role of GABA in anxiety and depression Depress. Anxiety 24 2007 495 517
36. A. Khama-Murad, and A.A. Mokrushin [Analysis of function of the glutamatergic and GABAergic mediator systems in the olfactory cortex of spontaneously hipertensive rats in vitro] Izv. Akad. Nauk. Ser. Biol. 2007 454 461
37. S.M. Kirpekar, and A.R. Wakade Release of noradrenaline from the cat spleen by potassium J. Physiol. 194 1968 595 608
38. N.M. Lambert, and C.S. Hartsough Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants J. Learn. Disabil. 31 1998 533 544
39. F.M. Leslie, K.A. Gallardo, and M.K. Park Nicotinic acetylcholine receptor-mediated release of [3H]norepinephrine from developing and adult rat hippocampus: direct and indirect mechanisms Neuropharmacology 42 2002 653 661
40. E.D. Levin, C.K. Conners, E. Sparrow, S.C. Hinton, D. Erhardt, W.H. Meck, J.E. Rose, and J. March Nicotine effects on adults with attention-deficit/ hyperactivity disorder Psychopharmacology 123 1996 55 63
41. E.D. Levin, F.J. McClernon, and A.H. Rezvani Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization Psychopharmacology 184 2006 523 539
42. 2+ level of mouse hippocampal synaptosomes Sheng Li Xue Bao 50 1998 449 452
43. O. Malkesman, and A. Weller Two different putative genetic animal models of childhood depression - a review Prog. Neurobiol. 88 2009 153 169
44. S. Matthies, S. Holzner, B. Feige, C. Scheel, E. Perlov, D. Ebert, L. Tebartz van Elst, and A. Philipsen ADHD as a serious risk factor for early smoking and nicotine dependence in adulthood J. Atten. Disord. 17 2013 176 186
45. S. Mc Fie, T.L. Sterley, F.M. Howells, and V.A. Russell Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar-Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder Brain Res. 1467 2012 91 103
46. E.L. Meyer, Y. Xiao, and K.J. Kellar Agonist regulation of rat alpha 3 beta 4 nicotinic acetylcholine receptors stably expressed in human embryonic kidney 293 cells Mol. Pharmacol. 60 2001 568 576
47. Y.S. Mineur, and M.R. Picciotto Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis Trends Pharmacol. Sci. 31 2010 580 586
48. S.N. Mitchell Role of the locus coeruleus in the noradrenergic response to a systemic administration of nicotine Neuropharmacology 32 1993 937 949
49. Murthy, K.S., 2006. Effects of Stress and Nicotine on ADHD Rat Models. Degree of Bachelor of Science, Faculty of the Worcester Polytechnic Institute.
50. M.C. Pardon, G.G. Gould, A. Garcia, L. Phillips, M.C. Cook, S.A. Miller, P.A. Mason, and D.A. Morilak Stress reactivity of the brain noradrenergic system in three rat strains differing in their neuroendocrine and behavioral responses to stress: implications for susceptibility to stress-related neuropsychiatric disorders Neuroscience 115 2002 229 242
51. K.J. Plessen, R. Bansal, H. Zhu, R. Whiteman, J. Amat, G.A. Quackenbush, L. Martin, K. Durkin, C. Blair, and J. Royal Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder Arch. Gen. Psychiatry 63 2006 795
52. S.R. Pliszka Pharmacologic treatment of attention-deficit/hyperactivity disorder: efficacy, safety and mechanisms of action Neuropsychol. Rev. 17 2007 61 72
53. C.S. Pomerleau, K.K. Downey, S.M. Snedecor, A.M. Mehringer, J.L. Marks, and O.F. Pomerleau Smoking patterns and abstinence effects in smokers with no ADHD, childhood ADHD, and adult ADHD symptomatology Addict. Behav. 28 2003 1149 1157
54. A.S. Potter, and P.A. Newhouse Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder Psychopharmacology 176 2004 182 194
55. M.W. Quick, and R.A. Lester Desensitization of neuronal nicotinic receptors J. Neurobiol. 53 2002 457 478
56. L. Raiteri, M. Raiteri, and G. Bonanno Coexistence and function of different neurotransmitter transporters in the plasma membrane of CNS neurons Prog. Neurobiol. 68 2002 287 309
57. V. Russell, S. Allie, and T. Wiggins Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder - the spontaneously hypertensive rat Behav. Brain Res. 117 2000 69 74
58. V.A. Russell Increased AMPA receptor function in slices containing the prefrontal cortex of spontaneously hypertensive rats Metab. Brain Dis. 16 2001 143 149
59. V.A. Russell, and T.M. Wiggins Increased glutamate-stimulated norepinephrine release from prefrontal cortex slices of spontaneously hypertensive rats Metab. Brain Dis. 15 2000 297 304
60. A.I. Sacaan, J.L. Dunlop, and G.K. Lloyd Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices J. Pharmacol. Exp. Ther. 274 1995 224 230
61. T. Sagvolden Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD) Neurosci. Biobehav. Rev. 24 2000 31 39
62. T. Sagvolden, E.B. Johansen, H. Aase, and V.A. Russell A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes Behav. Brain Sci. 28 2005 397 419 (discussion 419-368)
63. T. Sagvolden, V.A. Russell, H. Aase, E.B. Johansen, and M. Farshbaf Rodent models of attention-deficit/hyperactivity disorder Biol. Psychiatry 57 2005 1239 1247
64. S. Sasaki, T. Kuwabara, T. Yoshitomi, Y. Yoneda, K. Takenaka, T. Takesako, M. Tanaka, M. Hirata, S. Tanabe, and T. Nakata et al. Decreased hypothalamic and medullary GABA turnover in spontaneously hypertensive rats Cardiovasc. Res. 26 1992 261 264
65. S. Sasaki, T. Nakata, S. Kawasaki, J. Hayashi, M. Oguro, K. Takeda, and M. Nakagawa Chronic central GABAergic stimulation attenuates hypothalamic hyperactivity and development of spontaneous hypertension in rats J. Cardiovasc. Pharmacol. 15 1990 706 713
66. A.N. Schoffelmeer, J. Wemer, and A.H. Mulder Comparison between electrically evoked and potassium-induced (3)H-noradrenaline release from rat neocortex slices: role of calcium ions and transmitter pools Neurochem. Int. 3 1981 129 136
67. A receptors triggers anxiety at puberty Nat. Neurosci. 10 2007 469 477
68. H. Shen, N. Sabaliauskas, A. Sherpa, A.A. Fenton, A. Stelzer, C. Aoki, and S.S. Smith A critical role for α4βδ GABAA receptors in shaping learning deficits at puberty in mice Science 327 2010 1515 1518
69. M.M. Silveri, J.T. Sneider, D.J. Crowley, M.J. Covell, D. Acharya, I.M. Rosso, and J.E. Jensen Frontal lobe γ-aminobutyric acid levels during adolescence: associations with impulsivity and response inhibition Biol. Psychiatry 74 2013 296 304
70. S. Singer, S. Rossi, S. Verzosa, A. Hashim, R. Lonow, T. Cooper, H. Sershen, and A. Lajtha Nicotine-induced changes in neurotransmitter levels in brain areas associated with cognitive function Neurochem. Res. 29 2004 1779 1792
71. M. Skounti, A. Philalithis, and E. Galanakis Variations in prevalence of attention deficit hyperactivity disorder worldwide Eur. J. Pediatr. 166 2007 117 123
72. A receptor plasticity Psychoneuroendocrinology 34 Suppl. 1 2009 S91 S103
73. StatSoft I, 2012. STATISTICA (Data Analysis Software System), version 11. www.statsoft.com.
74. T.L. Sterley, F.M. Howells, and V.A. Russell Evidence for reduced tonic levels of GABA in the hippocampus of an animal model of ADHD, the spontaneously hypertensive rat Brain Res 2013 52 60
75. T.L. Sterley, F.M. Howells, and V.A. Russell Maternal separation increases GABA(A) receptor-mediated modulation of norepinephrine release in the hippocampus of a rat model of ADHD, the spontaneously hypertensive rat Brain Res. 1497 2013 23 31
76. A.V. Terry Jr., C.M. Hernandez, J.J. Buccafusco, and M. Gattu Deficits in spatial learning and nicotinic-acetylcholine receptors in older, spontaneously hypertensive rats Neuroscience 101 2000 357 368
77. K.I. Ueno, H. Togashi, K. Mori, M. Matsumoto, S. Ohashi, A. Hoshino, T. Fujita, H. Saito, M. Minami, and M. Yoshioka Behavioural and pharmacological relevance of stroke-prone spontaneously hypertensive rats as an animal model of a developmental disorder Behav. Pharmacol. 13 2002 1 13
78. U. Ungerstedt Stereotaxic mapping of the monoamine pathways in the rat brain Acta Physiol. Scand. Suppl. 367 1971 1 48
79. E.S. Vizi, and J.P. Kiss Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions Hippocampus 8 1998 566 607
80. C.K. Whalen, L.D. Jamner, B. Henker, J.G. Gehricke, and P.S. King Is there a link between adolescent cigarette smoking and pharmacotherapy for ADHD? Psychol. Addict. Behav. 17 2003 332 335
81. M.B. Wigestrand, Y.S. Mineur, C.J. Heath, F. Fonnum, M.R. Picciotto, and S.I. Walaas Decreased alpha4beta2 nicotinic receptor number in the absence of mRNA changes suggests post-transcriptional regulation in the spontaneously hypertensive rat model of ADHD J. Neurochem. 119 2011 240 250
82. S. Wonnacott Presynaptic nicotinic ACh receptors Trends Neurosci. 20 1997 92 98